Athletigen Technologies develops the Athletigen Performance Platform, an interpretive bioinformatics tool that presents sports genetics analysis in an athlete- and coach-friendly format. Its platform analyzes 850,000 genetic variants through a proprietary DNA analysis developed in partnership with Affymetrix. The company’s dashboard translates genetic indicators into personalized guidance on athleticism, nutrition, and sports psychology and is used by elite athletes, professionals and Rio 2016 Olympians. Athletigen has worked extensively with Olympic coaches and high-performance staff. The company plans to use the new financing to advance and expand its human performance platform globally and to accelerate adoption in the growing consumer genomics market. Athletigen is headquartered in Halifax, Nova Scotia.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Jan 2016